Endocan: A new biomarker associated with inflammation in type 2 diabetes mellitus?

Diabetes/Metabolism Research and Reviews

Volumn 31, Issue 5, 2015, Pages 479-480

  Rodrigues, Kathryna F ^a   Pietrani, Nathalia T ^a   Bosco, Adriana A ^b   Sousa, Lirlândia P ^a   Ferreira, Cláudia N ^a   Sandrim, Valeria C ^c   Gomes, Karina B ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Santa Casa de Belo Horizonte   (Brazil)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ENDOTHELIAL CELL SPECIFIC MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; PROTEOGLYCAN; UNCLASSIFIED DRUG; ESM1 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ANTHROPOMETRIC PARAMETERS; BODY MASS; CELL MIGRATION; CHRONIC KIDNEY DISEASE; CLINICAL EVALUATION; COMMUNITY CARE; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HIGH RISK POPULATION; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INFLAMMATION; LETTER; LEUKOCYTE ADHERENCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; RISK ASSESSMENT; RISK FACTOR; SEPSIS; WAIST CIRCUMFERENCE; AGED; BLOOD; CASE CONTROL STUDY; MIDDLE AGED;

AGED; BIOMARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEOGLYCANS; WAIST CIRCUMFERENCE;

EID: 84935047850     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.2639     Document Type: Letter

References (11)

1. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011; 11(2): 98-107.
2. Wellner M, Herse F, Janke J, et al. Endothelial cell specific molecule-1 - a newly identified protein in adipocytes. Horm Metab Res 2003; 35(4): 217-221.
3. Mikkelsen ME, Shah CV, Scherpereel A, et al. Lower serum endocan levels are associated with the development of acute lung injury after major trauma. J Crit Care 2012; 27(5): 522.e11-7.
4. American Diabetes Association. Standards of medical care in diabetes - 2012. Diabetes Care 2012; 35: S11-63.
5. Béchard D, Scherpereel A, Hammad H, et al. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol 2001; 167(6): 3099-106.
6. Janke J, Engeli S, Gorzelniak K, et al. Adipose tissue and circulating endothelial cell specific molecule-1 in human obesity. Horm Metab Res 2006; 38(1): 28-33.
7. Wang X, Yang W, Luo T, Wang JM, Jing Y. Serum endocan levels are correlated with the presence and severity of coronary artery disease in patients with hypertension. Genet Test Mol Biomarkers 2015; in press.
8. Celik T, Balta S, Karaman M, et al. Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan. Blood Press 2015; 24(1): 55-60.
9. Lee H, Choi H, Bae J. Endocan as a potential diagnostic or prognostic biomarker for chronic kidney disease. Kidney Int 2014; 86(6): 1079-1081.
10. Mihajlovic DM, Lendak DF, Brkic SV, et al. Endocan is useful biomarker of survival and severity in sepsis. Microvasc Res 2014; 93: 92-97.
11. Zhao W, Sun M, Li S, Wang Y, Liu J. Biological and clinical implications of endocan in gastric cancer. Tumour Biol 2014; 35(10): 10043-10049.